Researchers investigated alcohol usage, psychological health status, and alcohol-associated concerns among university students.
Not All COVID Patients Benefit From JAK Inhibitor
People randomized to the Janus kinase (JAK) inhibitor baricitinib (Olumiant) to treat COVID-19 pneumonia in a clinical trial only saw a survival benefit if they